1500006I duke university; to 18-0006.B1.0115--06 base award; biod can 8470038 $55,158
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,360,365
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $2,360,364.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,088 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$7 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,386,229 | |
| Supplemental Agreement for work within scope | $46,368 | |
| Supplemental Agreement for work within scope | $228,850 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $644,855 | |
| Original award | $55,158 |
Show all 13
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Duke University on June 7, 2019, with a ceiling value of $2.36 million under the Therapeutics Against Infectious Diseases Phase 1 parent IDIQ for establishment and operation of a Phase 1 clinical trial unit for therapeutics against infectious diseases.
Place of performance is Durham, NC. The order ultimate completion date is July 31, 2025. Pricing is cost, no fee. Duke University's Office of Research Administration Division executed this work.
Service Contract Inventory reporting shows Duke University invoiced $89 thousand in FY2020, declining to $13 thousand by FY2025. Labor intensity peaked in FY2022 at 0.2 FTEs and 423 contractor hours (derived rate $716.92/hr), declining to 0.0 FTEs by FY2025 with minimal invoicing. Duke University self-performed all reported hours with no subcontractors.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 7, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $2,360,365 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under HHSN272201500006I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award